$16.51
0.181.10%
al cierre: -
$16.37
-0.14-0.85%
After hour: Nov 7, 7:24 PM EDT
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
PG&E Corp tiene un precio objetivo de consenso de $20.82 basado en las calificaciones de 22 analistas. El máximo es $26, emitido por Mizuho el noviembre 27, 2024. El mínimo es $17, emitido por Evercore ISI Group el abril 28, 2025. Las 3 calificaciones de analistas más recientes fueron publicadas por Wells Fargo, UBS y Jefferies el octubre 28, 2025, octubre 24, 2025 y octubre 22, 2025, respectivamente. Con un precio objetivo promedio de $20.67 entre Wells Fargo, UBS y Jefferies, hay una 26.25% upside implícita para PG&E Corp según estas calificaciones más recientes de analistas.
Firmas de analistas que realizan recomendaciones1
Wells Fargo
UBS
Jefferies
BMO Capital
Barclays
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para PG&E
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/28/2025 | 40.51% | Wells Fargo | → $23 | Initiates | → Overweight | |||
10/24/2025 | 9.96% | UBS | $17 → $18 | Maintains | Neutral | |||
10/22/2025 | 28.29% | Jefferies | $20 → $21 | Maintains | Buy | |||
10/14/2025 | 52.73% | BMO Capital | $23 → $25 | Maintains | Outperform | |||
10/03/2025 | 22.18% | Jefferies | $22 → $20 | Maintains | Buy | |||
10/01/2025 | 28.29% | Barclays | $20 → $21 | Maintains | Overweight | |||
09/25/2025 | 19.13% | Morgan Stanley | $20 → $19.5 | Maintains | Equal-Weight | |||
09/18/2025 | 3.85% | UBS | $19 → $17 | Maintains | Neutral | |||
09/18/2025 | 22.18% | Morgan Stanley | $19 → $20 | Upgrade | Underweight → Equal-Weight | |||
07/22/2025 | 22.18% | Barclays | $22 → $20 | Maintains | Overweight | |||
05/22/2025 | 9.96% | Morgan Stanley | $18.5 → $18 | Maintains | Underweight | |||
05/19/2025 | 28.29% | Mizuho | $20 → $21 | Maintains | Outperform | |||
04/28/2025 | 3.85% | Evercore ISI Group | $15 → $17 | Maintains | In-Line | |||
04/25/2025 | 3.85% | Guggenheim | $16 → $17 | Maintains | Neutral | |||
04/23/2025 | 13.02% | Morgan Stanley | $17.5 → $18.5 | Maintains | Underweight | |||
04/23/2025 | 34.4% | Jefferies | $20 → $22 | Maintains | Buy | |||
04/14/2025 | 34.4% | BMO Capital | $23 → $22 | Maintains | Outperform | |||
04/09/2025 | 34.4% | Barclays | $23 → $22 | Maintains | Overweight | |||
03/20/2025 | 6.91% | Morgan Stanley | $16.5 → $17.5 | Maintains | Underweight | |||
03/19/2025 | 16.07% | UBS | $22 → $19 | Downgrade | Buy → Neutral | |||
02/18/2025 | 40.51% | BMO Capital | $21 → $23 | Maintains | Outperform | |||
02/14/2025 | 0.8% | Morgan Stanley | $20 → $16.5 | Downgrade | Equal-Weight → Underweight | |||
02/12/2025 | 34.4% | JP Morgan | → $22 | Assumes | → Overweight | |||
01/30/2025 | 34.4% | UBS | $24 → $22 | Maintains | Buy | |||
01/27/2025 | 40.51% | Barclays | $24 → $23 | Maintains | Overweight | |||
01/13/2025 | 28.29% | BMO Capital | → $21 | Initiates | → Outperform | |||
12/20/2024 | 22.18% | Morgan Stanley | $21 → $20 | Maintains | Equal-Weight | |||
12/19/2024 | 46.62% | UBS | $26 → $24 | Maintains | Buy | |||
12/17/2024 | 46.62% | Barclays | $25 → $24 | Maintains | Overweight | |||
11/27/2024 | 58.84% | Mizuho | $24 → $26 | Maintains | Outperform | |||
10/21/2024 | 52.73% | Barclays | $24 → $25 | Maintains | Overweight | |||
10/16/2024 | 46.62% | Mizuho | $23 → $24 | Maintains | Outperform | |||
10/14/2024 | 46.62% | Jefferies | → $24 | Initiates | → Buy | |||
09/25/2024 | 22.18% | Morgan Stanley | $19 → $20 | Maintains | Equal-Weight | |||
09/12/2024 | 46.62% | Barclays | $23 → $24 | Maintains | Overweight | |||
09/12/2024 | 46.62% | B of A Securities | → $24 | Reinstates | → Buy | |||
09/03/2024 | 58.84% | UBS | $24 → $26 | Maintains | Buy | |||
08/23/2024 | 16.07% | Morgan Stanley | $18 → $19 | Maintains | Equal-Weight | |||
07/30/2024 | 40.51% | Barclays | $22 → $23 | Maintains | Overweight | |||
07/26/2024 | 34.4% | Wells Fargo | $21 → $22 | Maintains | Overweight | |||
07/23/2024 | 9.96% | Morgan Stanley | $17 → $18 | Maintains | Equal-Weight | |||
07/22/2024 | 34.4% | Barclays | $21 → $22 | Maintains | Overweight | |||
06/24/2024 | 3.85% | Morgan Stanley | $18 → $17 | Maintains | Equal-Weight | |||
06/17/2024 | 28.29% | Barclays | $22 → $21 | Maintains | Overweight | |||
06/14/2024 | 28.29% | Citigroup | $19 → $21 | Maintains | Buy | |||
06/10/2024 | 34.4% | JP Morgan | $19 → $22 | Upgrade | Neutral → Overweight | |||
06/05/2024 | 34.4% | Barclays | $21 → $22 | Maintains | Overweight | |||
06/03/2024 | 34.4% | UBS | $22 → $22 | Reiterates | Buy → Buy | |||
05/28/2024 | 9.96% | Morgan Stanley | $16 → $18 | Maintains | Equal-Weight | |||
05/17/2024 | 40.51% | Mizuho | $21 → $23 | Maintains | Buy | |||
04/26/2024 | 28.29% | Wells Fargo | $20 → $21 | Maintains | Overweight | |||
04/26/2024 | 28.29% | Barclays | $20 → $21 | Maintains | Overweight | |||
04/23/2024 | 16.07% | JP Morgan | $18 → $19 | Maintains | Neutral | |||
04/10/2024 | 28.29% | Goldman Sachs | → $21 | Initiates | → Buy | |||
01/22/2024 | 16.07% | Barclays | $20 → $19 | Maintains | Overweight | |||
12/21/2023 | 3.85% | Morgan Stanley | $14 → $17 | Maintains | Equal-Weight | |||
12/20/2023 | 28.29% | Mizuho | $20 → $21 | Maintains | Buy | |||
12/05/2023 | 22.18% | Barclays | $18 → $20 | Maintains | Overweight | |||
11/17/2023 | 22.18% | Mizuho | $19 → $20 | Maintains | Buy | |||
10/27/2023 | 16.07% | Wells Fargo | $21 → $19 | Maintains | Overweight | |||
10/23/2023 | -2.25% | Evercore ISI Group | → $16 | Reinstates | → In-Line | |||
10/17/2023 | 9.96% | JP Morgan | $19 → $18 | Maintains | Neutral | |||
10/17/2023 | 9.96% | Barclays | $19 → $18 | Maintains | Overweight | |||
09/15/2023 | 16.07% | Mizuho | → $19 | Reiterates | Buy → Buy | |||
08/29/2023 | 16.07% | Mizuho | → $19 | Reiterates | Buy → Buy | |||
08/23/2023 | -14.47% | Morgan Stanley | $15 → $14 | Maintains | Equal-Weight | |||
08/23/2023 | 16.07% | Barclays | → $19 | Initiates | → Overweight | |||
08/07/2023 | 28.29% | UBS | $19 → $21 | Upgrade | Neutral → Buy | |||
07/28/2023 | 28.29% | Wells Fargo | $20 → $21 | Maintains | Overweight | |||
07/21/2023 | -8.36% | Morgan Stanley | $15 → $15 | Reiterates | Equal-Weight → Equal-Weight | |||
07/07/2023 | 28.29% | Guggenheim | $22 → $21 | Maintains | Buy | |||
06/23/2023 | -8.36% | Morgan Stanley | $15 → $15 | Reiterates | Equal-Weight → Equal-Weight | |||
06/01/2023 | 9.96% | UBS | $19 → $18 | Maintains | Neutral | |||
05/30/2023 | 28.29% | RBC Capital | $20 → $21 | Maintains | Outperform | |||
05/22/2023 | -8.36% | Morgan Stanley | $16 → $15 | Maintains | Equal-Weight | |||
04/26/2023 | -2.25% | Morgan Stanley | $15 → $16 | Maintains | Equal-Weight | |||
04/20/2023 | -8.36% | Morgan Stanley | $13 → $15 | Maintains | Equal-Weight | |||
04/03/2023 | 25.24% | Ladenburg Thalmann | → $20.5 | Initiates | → Buy | |||
03/10/2023 | 22.18% | RBC Capital | → $20 | Reiterates | → Outperform | |||
02/24/2023 | 16.07% | Credit Suisse | $18 → $19 | Maintains | Outperform | |||
02/22/2023 | -14.47% | Morgan Stanley | $15 → $14 | Maintains | Equal-Weight | |||
01/03/2023 | 3.85% | UBS | → $17 | Downgrade | Buy → Neutral | |||
12/14/2022 | 22.18% | Wells Fargo | $18 → $20 | Maintains | Overweight | |||
11/11/2022 | -14.47% | Morgan Stanley | $12.5 → $14 | Maintains | Equal-Weight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de PG&E (PCG)?
El último precio objetivo de PG&E (NYSE:PCG) fue comunicado por Wells Fargo el octubre 28, 2025. La firma de analistas fijó un precio objetivo para $23.00 que espera PCG a rise dentro de 12 meses (un posible 40.51% upside). 30 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre PG&E (PCG)?
La última calificación de analistas para PG&E (NYSE:PCG) fue proporcionada por Wells Fargo, y PG&E iniciado su overweight calificación.
¿Cuándo se produjo la última revisión al alza de PG&E (PCG)?
La última revisión al alza de PG&E Corp se produjo en septiembre 18, 2025, cuando Morgan Stanley elevó su precio objetivo a $20. Morgan Stanley anteriormente tenía an underweight para PG&E Corp.
¿Cuándo fue la última revisión a la baja de PG&E (PCG)?
La última revisión a la baja de PG&E Corp se produjo en marzo 19, 2025, cuando UBS cambió su precio objetivo de $22 a $19 para PG&E Corp.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para PG&E (PCG)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de PG&E, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de PG&E se registró el octubre 28, 2025, por lo que la próxima calificación estará disponible en torno al octubre 28, 2026.
¿Es correcta la calificación de los analistas sobre PG&E (PCG)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de PG&E (PCG) fue un iniciado con un precio objetivo de $0.00 a $23.00. El precio actual al que cotiza PG&E (PCG) es de $16.37, que es within del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.